IL33 and neoplasm: Genetic ablation of IL-33 signaling in ApcMin/+ mice or inhibition by using neutralizing antibodies led to reduced proliferation, increased apoptosis and diminished angiogenesis in polyps, which overall reduced the tumor burden [152].